Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Last Updated: December 4, 2021

DrugPatentWatch Database Preview

Par Form Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for PAR FORM, and what generic and branded alternatives to PAR FORM drugs are available?

PAR FORM has five approved drugs.

There is one tentative approval on PAR FORM drugs.

Summary for Par Form
US Patents:0

Drugs and US Patents for Par Form

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Form ZOLPIDEM TARTRATE zolpidem tartrate TABLET;SUBLINGUAL 201509-001 Aug 1, 2016 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Par Form LABETALOL HYDROCHLORIDE labetalol hydrochloride TABLET;ORAL 200908-002 Jul 10, 2012 AB RX No Yes ⤷  Free Forever Trial ⤷  Free Forever Trial
Par Form MAFENIDE ACETATE mafenide acetate FOR SOLUTION;TOPICAL 201511-001 Feb 12, 2013 AT RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Par Form FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride TABLET;ORAL 203836-001 Aug 19, 2016 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.